B of A Securities Upgrades JM Smucker to Buy, Raises Price Target to $155
B of A Securities analyst Peter Galbo upgrades JM Smucker (NYSE:SJM) from Neutral to Buy and raises the price target from $145 to $155.
JP Morgan Upgrades Westlake to Overweight, Announces $135 Price Target
JP Morgan analyst Jeffrey Zekauskas upgrades Westlake (NYSE:WLK) from Neutral to Overweight and announces $135 price target.
Credit Suisse Upgrades Apple to Outperform, Announces $201 Price Target
Credit Suisse analyst Shannon Cross upgrades Apple (NASDAQ:AAPL) from Neutral to Outperform and announces $201 price target.
Seagen For Sale? This Acquisition Target Is ‘Too Intriguing To Ignore,’ RBC Says
The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.”
HC Wainwright & Co. Upgrades Diffusion Pharmaceuticals to Buy, Announces $9.5 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Diffusion Pharmaceuticals (NASDAQ:DFFN) from Neutral to Buy and announces $9.5 price target.
RBC Capital Upgrades Seagen to Outperform, Raises Price Target to $188
RBC Capital analyst Gregory Renza upgrades Seagen (NASDAQ:SGEN) from Sector Perform to Outperform and raises the price target from $179 to $188.
Analyst Upgrades PPL, Bets Stock Will Re-Rate Higher: Here’s Why
Shares of PPL Corp. (NYSE: PPL) have had a prolonged period of underperformance, the company is a beneficiary of the Inflation Reduction Act, according to Bank of America Securities.
Kalinowski Research Upgrades McDonald’s to Buy
Kalinowski Research analyst Mark Kalinowski upgrades McDonald's (NYSE:MCD) from Neutral to Buy.
B of A Securities Upgrades PPL to Buy, Raises Price Target to $33
B of A Securities analyst Julien Dumoulin-Smith upgrades PPL (NYSE:PPL) from Neutral to Buy and raises the price target from $29 to $33.